Literature DB >> 18541687

Economic effects of clinical pharmacy interventions: a literature review.

Thomas De Rijdt1, Ludo Willems, Steven Simoens.   

Abstract

PURPOSE: Economic evaluations of clinical pharmacy interventions are reviewed.
SUMMARY: A variety of clinical pharmacy interventions have been assessed, but the body of evidence relating to any particular type of intervention is small. Cost-saving interventions comprise a small percentage of clinical pharmacy interventions, but they generated substantial savings. Clinical pharmacists provided added value by participating in multidisciplinary teams attending rounds. Clinical pharmacy interventions reduced preventable adverse drug events and prescribing errors, thereby yielding savings related to cost avoidance. Interventions relating to antibiotic therapy lowered costs of care without adversely affecting clinical outcomes. The results of cost-benefit analyses suggested that general clinical pharmacy interventions are associated with cost savings. Most economic evaluations of clinical pharmacy interventions suffered from a number of methodological limitations relating to the absence of a control group without clinical pharmacy interventions, limited scope of costs and outcomes, focus on direct health care costs only, exclusion of pharmacist employment cost, use of intermediate outcome measures, exclusion of health benefits, and absence of incremental cost analysis. Some avenues for designing future economic evaluations include the use of a control group, detailed descriptions of the interventions provided, evaluations conducted from a societal perspective, consideration of patients' health benefits when assessing economic effect of interventions and hospital costs, and the inclusion of sensitivity and incremental analyses.
CONCLUSION: Most pharmacoeconomic evaluations of clinical pharmacy interventions demonstrated limitations in their methodological quality and applicability to current practice. Future evaluations should use a comparative study design that includes the incremental cost-effectiveness or cost:benefit ratio of clinical pharmacy interventions from a societal perspective.

Entities:  

Mesh:

Year:  2008        PMID: 18541687     DOI: 10.2146/ajhp070506

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  43 in total

1.  Should Pharmacy Technicians Provide Clinical Services or Perform Patient Care Activities in Areas without a Pharmacist?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2010-09

2.  Analysis of cost avoidance from pharmacy students' clinical interventions at a psychiatric hospital.

Authors:  Austin R Campbell; Leigh Anne Nelson; Ellie Elliott; Robin Hieber; Roger W Sommi
Journal:  Am J Pharm Educ       Date:  2011-02-10       Impact factor: 2.047

3.  Physicians as executives: opportunities and strategies for health-system pharmacy leaders.

Authors:  Andre Harvin; Niesha Griffith; Robert J Weber
Journal:  Hosp Pharm       Date:  2014-11

4.  Epidemiology and cost analysis of pharmacist interventions at Ghent University Hospital.

Authors:  Barbara O M Claus; Fien M R Vandeputte; Hugo Robays
Journal:  Int J Clin Pharm       Date:  2012-07-19

5.  Analysis of clinical interventions and the impact of pediatric pharmacists on medication error prevention in a teaching hospital.

Authors:  Kelli J Cunningham
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

6.  Effect of a resident physician educational program on pediatric emergency department pharmacy interventions and medication errors.

Authors:  Megan E Foster; Donald E Lighter; Ashok V Godambe; Brandon Edgerson; Randy Bradley; Sandip Godambe
Journal:  J Pediatr Pharmacol Ther       Date:  2013-01

7.  Analysis of drug-related problems in three departments of a German University hospital.

Authors:  Rebekka Lenssen; Axel Heidenreich; Jörg B Schulz; Christian Trautwein; Christina Fitzner; Ulrich Jaehde; Albrecht Eisert
Journal:  Int J Clin Pharm       Date:  2015-10-28

Review 8.  Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature.

Authors:  James Gallagher; Suzanne McCarthy; Stephen Byrne
Journal:  Int J Clin Pharm       Date:  2014-09-14

Review 9.  A review of the methodological challenges in assessing the cost effectiveness of pharmacist interventions.

Authors:  Rachel A Elliott; Koen Putman; James Davies; Lieven Annemans
Journal:  Pharmacoeconomics       Date:  2014-12       Impact factor: 4.981

10.  The impact of pharmaceutical care on improving outcomes in patients with type 2 diabetes mellitus from China: a pre- and postintervention study.

Authors:  Chuanwei Xin; Xing Ge; Xiuli Yang; Mengmeng Lin; Cheng Jiang; Zhongni Xia
Journal:  Int J Clin Pharm       Date:  2014-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.